Free Trial

Evercore's Rating of Electra Therapeutics on 10/13/2026

On October 13, 2026, Evercore updated its outlook on Electra Therapeutics (NASDAQ:ETRA) with the action "Initiated Coverage", setting a "Outperform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Evercore Inc

DateCompanyAction
10/13/2026
TRAX
First Tracks Biotherapeutics
Reiterated Rating
10/13/2026
Target Corporation stock logo
TGT
Target
Set Price Target
10/13/2026
ServiceNow, Inc. stock logo
NOW
ServiceNow
Reiterated Rating
10/13/2026
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
Reiterated Rating
10/13/2026
Floor & Decor Holdings, Inc. stock logo
FND
Floor & Decor
Set Price Target
10/13/2026
Bob's Discount Furniture, Inc. stock logo
BOBS
Bob's Discount Furniture
Set Price Target
More Ratings From Evercore Inc